OncoAlert and ecancer weekly roundup for November 2 - 7, 2020
OncoAlert and ecancer weekly roundup for November 2 - 7, 2020
SAFIR 02: Durvalumab compared to maintenance chemotherapy for metastatic non-small cell lung cancer
PIONeeR: Understanding PD-L1 resistances in non-small cell lung cancer
VHL/HIF and VEGF inhibitors in clear cell renal cell carcinoma
The ENA virtual meeting 2020
Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more than 1,000 patients
Development of novel inhibitors of KRASG12C
Impact of angiotensin II pathway inhibition on tumour response to anti PD(L)1 based therapy
Biomarker-driven clinical trials: promises and pitfalls
Key themes, highlights and importance of this year's IBCD 2020 meeting
How current assay approval policies are leading to unintended imprecision medicine
OncoAlert and ecancer weekly roundup for October 19-26, 2020